Cabaletta Bio, Inc. — Director's Dealing 2022

Oct 20, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cabaletta Bio, Inc. (CABA)
CIK: 0001759138
Period of Report: 2022-10-19

Reporting Person: Nichtberger Steven (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-19	Common Stock	P	8127	$1.2492	Acquired	986483	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	363000	Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.